Moderna, Inc. Common Stock vs. Twist Bioscience Corporation Common Stock
MRNA
Moderna, Inc. Common Stock
$142.73 +7.06%
VS TWSTTwist Bioscience Corporation Common Stock
$145.59 +6.79%
Moderna, Inc. Common Stock and Twist Bioscience Corporation Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| MRNA | TWST | |
|---|---|---|
| Market Cap | $69.62 billion | $8.55 billion |
| Revenue (TTM) | $2.23 billion | $431.80 million |
| Net Income (TTM) | $-3,151,000,000 | $-136,717,000 |
MRNA leads on 2 of 3 size & scale factors.
Valuation
| MRNA | TWST | |
|---|---|---|
| Price / Book | 10.30 | 19.18 |
| Price / Sales | 31.25 | 19.80 |
MRNA and TWST split the valuation factors evenly.
Profitability
| MRNA | TWST | |
|---|---|---|
| Net Margin | -141.43% | -31.66% |
| Return on Equity | -46.61% | -30.67% |
TWST leads on 2 of 2 profitability factors.
Risk & Sentiment
| MRNA | TWST | |
|---|---|---|
| Short Interest | 0.01% | 0.08% |
MRNA leads on 1 of 1 risk & sentiment factors.
Dig deeper: MRNA overview, MRNA financials, TWST overview, TWST financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.